Fig. 6
- ID
- ZDB-FIG-221210-14
- Publication
- Xiong et al., 2021 - SLC1A1 mediated glutamine addiction and contributed to natural killer T-cell lymphoma progression with immunotherapeutic potential
- Other Figures
- All Figure Page
- Back to All Figure Page
|
Clinical outcome according to EAAT3 expression in patients with NKTCL. (a and b) Progression-free survival (PFS, upper panel) and overall survival (OS, lower panel) according to tumor EAAT3 expression in all the patients (a), and stage I-II or III-IV patients (b) treated with asparaginase-based regimens. (c) Tumor EAAT3 expression in stage I-II or III-IV patients. (d) Multivariate analysis of predictors indicated on the left (EAAT3 and IPI, EAAT3 and PINK, or EAAT3 and PINK-E) for PFS and OS in NKTCL. Hazard ratio (HR), 95% confidence interval (95% CI) and P value were indicated on the right of each forest plot. P values in (a) and (b) were calculated with log-rank test. P value in (c) was calculated with Pearson's chi-square test. P values in (d) was calculated with Cox proportional hazards models. |